Results 181 to 190 of about 1,015,736 (307)
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source
The Anatomy of Phi Thickening Development in <i>Brassica oleracea</i> Roots. [PDF]
Collings DA, Aleamotuʻa M, McCurdy DW.
europepmc +1 more source
Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim +7 more
wiley +1 more source
Crown roots dominate nitrate uptake in maize (Zea mays) under varying soil moisture conditions. [PDF]
Jiang Y, Whalen JK.
europepmc +1 more source
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic +10 more
wiley +1 more source
Belowground growth is the primary driver of radial oxygen loss from Typha angustifolia to sediment. [PDF]
Stein IR, Cardon ZG.
europepmc +1 more source
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani +9 more
wiley +1 more source
Characterization of the MeWRKY12-<i>MeSSIV</i> Regulatory Module and <i>MeWRKY12</i> Promoter Activity in Cassava. [PDF]
Guo YQ +11 more
europepmc +1 more source
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source
MycorrhizaFinder: a user-friendly machine-learning tool to quantify endomycorrhizal colonisation of nursery and field roots. [PDF]
Kowal J +12 more
europepmc +1 more source

